I propose to take Questions Nos. 1184 and 1233 together.
Medicines containing fluconazole currently marketed in Ireland are subject to prescription.
The criteria and procedures for authorisation of medicines and/or reclassification of medicines from prescription control to non-prescription are set out in EU and national legislation. The Irish Medicines Board (IMB) makes a determination on an application for authorisation of a medicine based on a scientific assessment of the application and data submitted by the applicant.
Every application for authorisation or reclassification is evaluated on a case by case basis, based on the merits of the data submitted.
In this particular case, I understand that communication between the Irish Medicines Board and the applicant is ongoing. Consequently, it would be inappropriate for me to comment on any particular application for authorisation or reclassification at this time.